C68 - Cognitive Impairment Due to Alzheimer's Disease: Using Old Skills and New Tools for Diagnosis and Treatment

Event Time: Monday April 23, 2018 7:00 am to 9:00 am
Topic(s): Aging, Dementia, Cognitive, and Behavioral Neurology, Foundations in Clinical Neurology for APPs
Director(s): David Knopman MD, FAAN
Description: This program will focus on important topics in the diagnosis of cognitive impairment due to Alzheimer's disease. We will discuss the basics of the clinical diagnosis, the role of genetics in diagnosis and information for patients and families, the role of clinical and experimental imaging in the diagnosis of AD including the role for the new biomarker-based diagnostic approach to AD, and where we stand with treatment for AD. This program complements C80: Present and Future Biomarkers in Dementia: A Case-based Approach and C91: Chronic Traumatic Encephalopathy: Update, but covers independent topics.
Completion Message: Participants should be able to describe the continuum of cognitive function in the Alzheimer spectrum, understand the major and minor genetic influences on AD, describe the evolving biomarker diagnostic process for defining AD as a pathophysiology, and describe the appropriate indications for cholinesterase inhibitors and memantine.
CME Credits: 2
Core Competencies: Patient Care, Medical Knowledge

Ready to register for the 2019 AAN Annual Meeting?

Register Now

Related Courses